The Department of Agriculture (DA) has lifted its temporary ban on the importation of domestic and wild birds and related products—including poultry meat, day-old chicks, eggs, and semen—originating from Australia.
The ban was initially instituted under DA Memorandum Order No. 21, issued in June last year, following reported outbreaks of Highly Pathogenic Avian Influenza (HPAI).
Australian agriculture authorities and the World Organisation for Animal Health (WOAH) have confirmed that all reported bird flu cases in Australia had been resolved, with no new outbreaks occurring since June 13, 2025. Under WOAH Terrestrial Animal Health Code, Australia is now officially recognized as HPAI‑free.
Following thorough assessment, the DA determined that the risk of bird flu contamination via Australian poultry imports is negligible. On this basis, the department issued an memorandum order No. 39 immediately lifting the import ban.
Future shipments of the affected commodities will now proceed, subject to existing DA regulations and biosecurity requirements. Poultry goods produced in Australia on or after July 25, according to the Bureau of Animal Industry, will be allowed entry to the Phlippines.
“This diversifies our sources of poultry, especially with the expected increase in demand as we head towards the Christmas season,” said Agriculture Secretary Francisco P. Tiu Laurel Jr. “This aligns with the vision of President Ferdinand Marcos Jr. of a food-secure Philippines.”
Reopening the Australian market—especially of day-old chicks and poultry meat—could ease supply pressure, stabilize prices, and support local production during transition periods.
However, the DA emphasized that standard import controls, including health certifications, testing, and sanitary protocols, remain in full effect to safeguard domestic poultry industries. Non‑compliance may lead to denial of entry or quarantine.
The order took effect immediately and applies to all pending and forthcoming import arrangements involving Australian poultry products. The DA will continue to monitor global HPAI developments and may adjust import policies should new risks emerge.
